SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016636
Filing Date
2023-05-12
Accepted
2023-05-12 16:11:04
Documents
98
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 840369
2 ex10-1.htm EX-10.1 88349
3 ex10-2.htm EX-10.2 78856
4 ex10-3.htm EX-10.3 513430
5 ex31-1.htm EX-31.1 11792
6 ex31-2.htm EX-31.2 8131
7 ex32-1.htm EX-32.1 5302
8 ex32-2.htm EX-32.2 5294
9 ex10-2_001.jpg GRAPHIC 17061
  Complete submission text file 0001493152-23-016636.txt   6221995

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE bfri-20230331.xsd EX-101.SCH 53137
11 XBRL CALCULATION FILE bfri-20230331_cal.xml EX-101.CAL 75455
12 XBRL DEFINITION FILE bfri-20230331_def.xml EX-101.DEF 204942
13 XBRL LABEL FILE bfri-20230331_lab.xml EX-101.LAB 404893
14 XBRL PRESENTATION FILE bfri-20230331_pre.xml EX-101.PRE 324884
92 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 677759
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 23915771
SIC: 2834 Pharmaceutical Preparations